GENB
Generate Biomedicines, Inc.Financial Services·Asset Management
$13.12
$1.7B market cap
Revenue
$7.2M
Free Cash Flow
$-84.2M
Rev Growth
+0.0%
FCF Margin
-1165.1%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5
2-Year Price History
$14.53+14.9%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 7.2 | -60.8 | -64.1 | -61.5 | -80.4 | -84.2 | -3.8 | 516.6 | 65.6 | 128.2 | -55.1% | -334.3x | -- |
Valuation & Metrics
Market Stats
Price$13.12
Market Cap$1.7B
Enterprise Value$1.2B
P/S Ratio232.8x
P/FCF--
EV/FCF--
FCF Margin (TTM)-1165.1%
FCF Yield-5.0%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$7.2M
Net Income$-61.5M
Free Cash Flow$-84.2M
Revenue Growth (YoY)+0.0%
EBITDA Margin-842.2%
Net Margin-850.6%
FCF Margin-1165.1%
CapEx % of Revenue52.3%
SBC % of Revenue0.0%
ROIC-55.1%
WC Change % Rev0.0%
Interest Coverage-334.3x
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares3.2M
Days to Cover9.7
Change (vs Prior)+53.0%
Need at least 2 settlement dates for chart
Employees
Headcount312
Revenue / Employee$23,154
Gross Profit / Employee$12,663
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
66.1%
51 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
0.2%
4 filers
Vanguard, iShares, SPDR
Market makers
0.1%
2 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
Not enough quarterly ownership history to chart yet.
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| Flagship Pioneering Inc. | $783M | $12.50 | +$783M | +$783M | — | $1.16B |
| FMR LLC | $52.7M | $12.50 | +$52.7M | +$52.7M | — | $1.89T |
| Capital World Investors | $50.1M | $12.50 | +$50.1M | +$50.1M | — | $732.46B |
| BRAIDWELL LP | $44.9M | $12.50 | +$44.9M | +$44.9M | — | $2.63B |
| JPMORGAN CHASE & CO | $33.9M | $12.50 | +$36.8M | +$33.9M | — | $1.47T |
| PRICE T ROWE ASSOCIATES INC /MD/ | $26.4M | $12.50 | +$26.4M | +$26.4M | — | $864.93B |
| ARCH Venture Management, LLC | $24.3M | $12.50 | +$24.3M | +$24.3M | — | $677M |
| HARBOURVEST PARTNERS LLC | $21.5M | $12.50 | +$21.5M | +$21.5M | — | $101M |
| BAKER BROS. ADVISORS LP | $17.8M | $12.50 | +$17.8M | +$17.8M | — | $16.13B |
| HARVARD MANAGEMENT CO INC | $13.9M | $12.50 | +$13.9M | +$13.9M | — | $1.82B |
| NVIDIA CORP | $10.4M | $12.50 | +$10.4M | +$10.4M | — | $18.37B |
| Siren, L.L.C. | $9.2M | $12.50 | +$9.2M | +$9.2M | — | $3.61B |
| Davern Capital Partners, LP | $7.4M | $12.50 | +$7.4M | +$7.4M | — | $335M |
| Alyeska Investment Group, L.P. | $6.3M | $12.50 | +$6.3M | +$6.3M | — | $35.33B |
| ARK Investment Management LLC | $6.2M | $12.50 | +$6.2M | +$6.2M | — | $12.86B |
| MILLENNIUM MANAGEMENT LLC | $4.7M | $12.50 | +$4.7M | +$4.7M | — | $127.40B |
| UBS Group AG | $4.5M | $12.50 | +$4.5M | +$4.5M | — | $562.11B |
| Affinity Asset Advisors, LLC | $4.4M | $12.50 | +$4.4M | +$4.4M | — | $1.60B |
| MORGAN STANLEY | $4.2M | $12.50 | +$4.2M | +$4.2M | — | $1.65T |
| ExodusPoint Capital Management, LP | $3.9M | $12.50 | +$3.9M | +$3.9M | — | $10.04B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BEARISH
Holders
-9.20%
avg per quarter
Holders (ex-self)
—
excl. this stock
Buyers (this Q)
-9.20%
57 buyers · $1.16B in
Sellers (this Q)
+0.00%
0 sellers · $0.00B out
alpha coverage: 100% of $ has a lifetime-alpha record
Holder behavior (holder profile)source: holder
On big dips (−10%+)
-2.1%
how holders react when this stock falls
On quiet Qs
-1.0%
−10% to +10% baseline
On rallies (+10%+)
-5.3%
how they react when this stock rises
Holders' portfolio flow this Q
+164.0%
inflows — adds are organic
Sellers' portfolio flow this Q
+0.0%
Sellers' overall flow ~ flat.
New buyers this quarter
Top-5 holders · 83.4%
Flagship Pioneering Inc.--
FMR LLC--
Capital World Investors--
BRAIDWELL LP--
JPMORGAN CHASE & CO--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
Not enough holder history to plot.
Analyst Coverage
Analyst Coverage
Price Targets
Last Quarter (2 analysts)$23.507910.0%
Last Year (2 analysts)$23.507910.0%
Current Price$13.12
Analyst Ratings
2
Buy: 2Consensus: Buy
Corporate
Order Flow (FINRA, ~3w lag)
22.6%retail+6.2pp
28.7%dark+0.8pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.